European Industry Objects to Disclosure of Trial Information

Drug Industry Daily
A A
The UK BioIndustry Association and EuropaBio are calling for European regulators to drop plans to Phase I clinical trial reports, saying the information they contain is commercially sensitive.

To View This Article:

Login

Subscribe To Drug Industry Daily